Culturally Tailored Educational Video to Promote Lung Cancer Screening in Vulnerable Communities
Key facts
- Who runs it
- Thomas Jefferson University
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 11 people enrolled
- Started
- 1 Mar 2023
- Ended
- 19 Feb 2025
- Type of study
- Interventional, 3 groups
- Treatments tested
- Discussion
- Media Intervention
- Interview
- Test
- Record updated
- 17 February 2026
- Why it stopped
- Trial is terminated due to lack of staffing
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- AIM 1: Participants must be African American, Korean, or Chinese adults who have either: a history of smoking, a history of lung cancer, or who have undergone lung cancer screening
- AIM 2: Participants must be African American, Korean, or Chinese adults who have either: a history of smoking, a history of lung cancer, or who have undergone lung cancer screening
- AIM 3: Those who are African American, Korean or Chinese, and are eligible for lung cancer screening, based on current screening guidelines: Current or former smokers who are between 50 and 80 years of age and who have smoked at least one pack a day for 20 years or two packs a day for 10 years
Who cannot take part
- AIM 1: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have one of the following: a history of smoking, a history of lung cancer, or have undergone lung cancer screening
- AIM 2: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have one of the following: a history of smoking, a history of lung cancer, or have undergone lung cancer screening
- AIM 3: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have a history of smoking; those who have been diagnosed with lung cancer; those who have undergone lung cancer screening in the past
Where in United States
- Thomas Jefferson University HospitalPhiladelphia, United StatesNo longer taking part
About the trial
What the trial wants to find out
This clinical trial evaluates the impact of a culturally tailored educational video on the perceptions of lung cancer and lung cancer screening in vulnerable communities. Lung cancer is the most common cancer type. African-American communities have a higher rate than any other racial or ethnic group in the United States and accounts for the highest number of deaths among African-Americans. Lung cancer is in the top three causes of cancer death among Asian men and women. Research has shown that low-income, minority and immigrant individuals may be under resourced to make decisions about prevention programs and early detection measures for lung cancer. A culturally tailored educational video may be an effective method to help people learn about lung cancer, susceptibility toward lung cancer and lung cancer screening. This may increase lung cancer screening in vulnerable communities.
The 3 groups in the trial
- Arm I (Aim 1) (focus group)Treatment being tested
Participants participate in a focus group over 1 hour in support of the development of a culturally tailored educational video on study.
Treatment: Discussion
- Arm II (Aim 2) (video, interview)Treatment being tested
Participants watch a culturally tailored educational video over 3-5 minutes and then immediately undergo an interview in support of the refinement of a culturally tailored educational video on study.
Treatment: Media Intervention and Interview
- Arm III (Aim 3) (video, test)Treatment being tested
Participants watch a culturally tailored educational video over 3-5 minutes and complete a brief test pre- and post-video over 30 minutes on study.
Treatment: Media Intervention and Test
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Breathe Easier, Philadelphia! Engaging Vulnerable Communities for Innovative Lung Cancer Care
- Record updated
- 17 February 2026